EPS Bio Technology Corp. (TPEX:4183)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.15
+0.15 (0.94%)
Jan 22, 2026, 12:57 PM CST
-31.28%
Market Cap384.37M
Revenue (ttm)497.19M
Net Income (ttm)-14.24M
Shares Out23.80M
EPS (ttm)-0.60
PE Ration/a
Forward PEn/a
Dividend0.67 (4.19%)
Ex-Dividend DateAug 28, 2025
Volume32,000
Average Volume14,873
Open16.05
Previous Close16.00
Day's Range15.90 - 16.15
52-Week Range15.65 - 23.65
Beta0.20
RSI35.66
Earnings DateMar 11, 2026

About EPS Bio Technology

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan. [Read more]

Sector Healthcare
Founded 2006
Employees 109
Stock Exchange Taipei Exchange
Ticker Symbol 4183
Full Company Profile

Financial Performance

In 2024, EPS Bio Technology's revenue was 451.08 million, a decrease of -4.06% compared to the previous year's 470.17 million. Earnings were 17.31 million, a decrease of -17.54%.

Financial Statements